Abstract

BackgroundGlioblastoma (GBM) is a highly aggressive and malignant brain tumor. Despite aggressive treatment, GBM has a poor prognosis, and it is difficult to eliminate using current treatment strategy. Moreover, recurrence...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call